Follow-on biologics: data exclusivity and the balance between innovation and competition
Publication
, Journal Article
Grabowski, HG
Published in: Nature Reviews Drug Discovery
June 2008
Duke Scholars
Published In
Nature Reviews Drug Discovery
Publication Date
June 2008
Volume
7
Issue
6
Start / End Page
479 / 488
Related Subject Headings
- Pharmacology & Pharmacy
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 31 Biological sciences
- 11 Medical and Health Sciences
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Grabowski, H. G. (2008). Follow-on biologics: data exclusivity and the balance between innovation and competition. Nature Reviews Drug Discovery, 7(6), 479–488.
Grabowski, Henry G. “Follow-on biologics: data exclusivity and the balance between innovation and competition.” Nature Reviews Drug Discovery 7, no. 6 (June 2008): 479–88.
Grabowski HG. Follow-on biologics: data exclusivity and the balance between innovation and competition. Nature Reviews Drug Discovery. 2008 Jun;7(6):479–88.
Grabowski, Henry G. “Follow-on biologics: data exclusivity and the balance between innovation and competition.” Nature Reviews Drug Discovery, vol. 7, no. 6, June 2008, pp. 479–88.
Grabowski HG. Follow-on biologics: data exclusivity and the balance between innovation and competition. Nature Reviews Drug Discovery. 2008 Jun;7(6):479–488.
Published In
Nature Reviews Drug Discovery
Publication Date
June 2008
Volume
7
Issue
6
Start / End Page
479 / 488
Related Subject Headings
- Pharmacology & Pharmacy
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 31 Biological sciences
- 11 Medical and Health Sciences
- 06 Biological Sciences